Clinical Trial Update: A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 study evaluating interaction between tasisulam and midazolam in advanced cancer patients; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Midazolam (Midazolam)
• Tasisulam (tasisulam)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Advanced Cancer | Phase 1 | Status: TERMINATED | Results posted: 2019-03-18